Articles and source-linked reference material filed under this topic.
ARA-290 Peptide: Benefits, Uses, Side Effects, Dosage, and Research ARA-290 peptide, also called cibinetide, is an investigational erythropoietin-derived peptide studied for nerve-related and inflammatory conditions, es…
Read articleChronic neuropathic pain can last for months or even years after a nerve injury. Many available treatments help manage pain, but they do not always support the repair of damaged nerves. This has led researchers to study…
Read articleDiabetes affects millions of people around the world and leads to serious health problems. Research shows that the ARA-290 peptide may help ease some of these problems. It targets special receptors in damaged tissues. S…
Read articleKey Takeaways Common Side Effects: Many users report mild injection site reactions and transient fatigue. Serious Risks: While rare, some studies suggest potential for immune modulation effects. Regulatory Status: ARA-2…
Read articleKey Takeaways ARA-290 is available for research purposes only and is not FDA-approved for therapeutic use[1] Published clinical studies used doses ranging from 4 mg subcutaneously every other day to daily administration…
Read articleKey Takeaways ARA-290 is not FDA-approved and remains available only for research purposes, significantly limiting legitimate access options Research-grade ARA-290 typically costs $200-$600 per vial (2-5mg) from license…
Read articleARA-290 Peptide Research in Inflammation and Tissue Repair May 9, 2023 ARA-290 was developed by researchers to specifically bind to the EPO receptor (EPOR) on non-erythroid cells, such as neurons, endothelial cells, and…
Read articleResearch Applications of the ARA-290 Peptide by Dr. Usman | Feb 24, 2023 | Research Contents: ARA-290 Peptide Overview ARA-290 Studies on Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain ARA-290 Peptid…
Read article